SEKISUI to Provide Metrix COVID/Flu Test to the POC and Home Test Markets
SEKISUI Diagnostics has launched the Metrix COVID/Flu Test, a rapid molecular diagnostic for SARS-CoV-2 and influenza.
Read MorePosted by Chris Wolski | Apr 2, 2025 | POC Rapid Assays |
SEKISUI Diagnostics has launched the Metrix COVID/Flu Test, a rapid molecular diagnostic for SARS-CoV-2 and influenza.
Read MorePosted by Chris Wolski | Apr 1, 2025 | Sexually Transmitted Diseases |
A new self-testing microchip for HIV detection aims to provide an affordable, rapid, and accessible way to detect early HIV infections.
Read MorePosted by Chris Wolski | Mar 26, 2025 | Unknown Origin & Other Cancer Types |
Veracyte’s WGS-based MRD testing platform demonstrated earlier cancer detection in muscle-invasive bladder cancer (MIBC) patients.
Read MorePosted by Chris Wolski | Mar 24, 2025 | Covid 19 |
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Read MorePosted by Chris Wolski | Mar 24, 2025 | Covid 19 |
The COVID-19 pandemic has reshaped healthcare, diagnostics, and public health preparedness, leaving lasting impacts on the industry.
Read More